A phase 1 trial of copanlisib plus ibrutinib in relapsed/refractory mantle cell lymphoma

BLOOD ADVANCES

ELSEVIER

1. Memorial Sloan-Kettering Cancer Center (MSK)
2. Bayer
3. MSK Lymphoma SPORE [P50 CA192937]
4. NIH/NCI Cancer Center Support Grant [P30 CA008748]
5. ASCO Young Investigator Award
6. ASH Clinical Scholar Award
7. Lymphoma Research Foundation Clinical Research Mentoring Program
8. George L. Ohrstrom Foundation, Steven A. Greenberg Award